Oakville, ON, April 15, 2020 – Aspen Pharmacare Canada Inc. is proud to launch ASPEN-Dienogest, a generic drug whose bioequivalence to the brand product VISANNE® has been demonstrated the management of pelvic pain associated with endometriosis. ASPEN-Dienogest provides the same efficacy and safety as the brand product, at a lower cost to patients.
ASPEN-Dienogest is now available at pharmacies across Canada. ASPEN-Dienogest will be listed on most provincial formularies and private insurance by June 15th. Please check your provincial plans for coverage.